Skip to main content
Clinical Trials/NCT06713525
NCT06713525RecruitingNot Applicable

Copenhagen Pancreatic Cancer Study (COPAN)

Inna Chen, MD1 site in 1 country8,000 target enrollmentStarted: February 2, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
8,000
Locations
1
Primary Endpoint
Overall survival

Study Overview

Brief Summary

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Detailed Description

The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC.

The study aims to:

  1. To compile detailed demographic information of patients with PC.
  2. To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond.
  3. To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy.
  4. To assess short-term and long-term outcomes, including survival rates, complications, and quality of life.
  5. To identify prognostic and predictive factors within the real-world cohort.

8. To investigate the impact of PC and treatment on patients' quality of life.

4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically confirmed pancreatic cancer

Exclusion Criteria

  • Not provided

Arms & Interventions

Patients with PC are referred to Comprehensive Pancreatic Cancer Center at Herlev Hospital

Outcomes

Primary Outcomes

Overall survival

Time Frame: 3 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Inna Chen, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Inna Chen, MD

MD

Herlev Hospital

Study Sites (1)

Loading locations...

Similar Trials

Observational Copenhagen Pancreatic Cancer... | Clinical Trial